Last reviewed · How we verify

NCT04254250

Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation

Completed Last updated 27 February 2026
What this trial tests

trial testing Preoperative risk estimation of disc herniation recurrence in Intervertebral Disc Herniation in 386 participants. Completed in 25 February 2026.

Timeline
10 February 2020
Primary endpoint
10 August 2023
25 February 2026

Quick facts

Lead sponsorNovosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan
StatusCompleted
Study typeOBSERVATIONAL
Enrollment386
Start date10 February 2020
Primary completion10 August 2023
Estimated completion25 February 2026
Sites2 locations across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan

Who can join

Adults 18 to 60, any sex, with Intervertebral Disc Herniation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia. The current study is prospective observational study to evaluate the efficacy of preoperative estimation of disc herniation recurrence among patients with lumbar disc herniation using predictive mathematical model at terms 3 years postoperatively . It is expected to enroll 350 patients aged 18-70 with lumbar disc herniation. Risk estimation of disc herniation recurrence will be evaluated preoperatively, then patient will undergo conventional microdiscectomy. Postoperative eximanation will include Visits every 6-months during 3 years to evaluate clinical outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04254250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing